Medications

Pfizer painkiller gets longer patent protection (Update)

Drugmaker Pfizer Inc. said Tuesday that a new patent on one of its top drugs, anti-inflammatory painkiller Celebrex, extends its U.S. patent protection by 18 months, potentially bringing the company a few billion dollars ...

Medications

FDA expands approval of Bayer cancer drug (Update)

The U.S. Food and Drug Administration on Monday expanded approval of a Bayer cancer pill to treat tumors of the intestinal tract that do not respond to other treatments.

Health

Hot flashes take toll on life, health, and work

Hot flashes put a damper on women's health and productivity at work and pump up the cost of health care. A study published online this month in Menopause, the journal of the North American Menopause Society (NAMS), has put ...

Medications

Pfizer disputes suit claiming Zoloft doesn't work

(AP)—The maker of Zoloft is being sued in an unusual case alleging the popular antidepressant has no more benefit than a dummy pill. The federal lawsuit, filed in California, argues that patients who took it should be reimbursed ...

Other

Pfizer Q4 net jumps on sale of nutrition business

Pfizer Inc.'s fourth-quarter profit more than quadrupled, despite competition from generic drugs hurting sales of Lipitor and other medicines, because of a $4.8 billion gain from selling its nutrition business. The drugmaker's ...

Medications

Drug companies forge partnerships with top schools

(AP)—Pharmaceutical companies that can no longer rely on lucrative patents to drive profits are increasingly teaming up with academia in search of the next big drug discovery.

Oncology & Cancer

Genetic CRC risk likely mediated by differential adenoma risk

(HealthDay)—Much of the genetic risk for colorectal cancer (CRC) in the general population is mediated by differential adenoma risk, according to research published in the January issue of Gastroenterology.

Arthritis & Rheumatism

Web-based QoL tool beneficial in juvenile idiopathic arthritis

(HealthDay)—Children with arthritis who use a Web-based application to monitor health-related quality of life (HRQoL) have more discussions with their rheumatologist about psychosocial issues, and their physicians are more ...

page 35 from 40